http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#head http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#assertion http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#provenance http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#publicationInfo http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#assertion http://bio2rdf.org/drugbank:DB00315 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://bio2rdf.org/drugbank:DB01200 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://purl.org/dc/terms/identifier drugbank_resource:DB00315_DB01200 http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://purl.org/dc/terms/title DDI between Zolmitriptan and Bromocriptine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, bromocriptine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. Use of two serotonin modulators, such as zolmitriptan and bromocriptine, increases the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00315_DB01200 http://www.w3.org/2000/01/rdf-schema#label DDI between Zolmitriptan and Bromocriptine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, bromocriptine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. Use of two serotonin modulators, such as zolmitriptan and bromocriptine, increases the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. [drugbank_resource:DB00315_DB01200] http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#provenance http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#publicationInfo http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#signature.MCwCFH02PYh3lUeh http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#signature.MCwCFH02PYh3lUeh http://purl.org/nanopub/x/hasSignature MCwCFH02PYh3lUehRK+/rU+6ukO3hUyRAhQhCwglQhBdrKOZcN5Pg+f3zXhnfA== http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#signature.MCwCFH02PYh3lUeh http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://purl.org/dc/terms/created 2018-03-30T11:13:05.839+02:00 http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U#signature.MCwCFH02PYh3lUeh http://bio2rdf.org/drugbank_resource:DB00315_DB01200_nanopub.RAi17buyrVo83VYWxXdw8JqY-HqCX1Iu9UzF9kCgyJI-U http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234